Rethinking Tuberculosis Therapy for the Very Old: Fluoroquinolone Regimens Emerge as a Safer Bet
A retrospective study of 184 tuberculosis patients over 70 found that fluoroquinolone-containing regimens outperformed the standard pyrazinamide-based therapy in both ...
